Table 1.
Sociodemographic and clinical characteristics by group.
| HC (n = 20) | PSP (n = 19) | Stat/ p | |
|---|---|---|---|
| Age | 73.65 (5.7) | 74.79 (7.4) | T = 0.543/p = .910 |
| Years of education | 9.9 (3.7) | 7.4 (4.3) | T = 1.648/p = .120 |
| Sex (male/female) | 10/10 | 12/7 | χ2 = 0.686/p = .408 |
| MMSE | 29.05 (1.1) | 23.19 (4.67) | T = 5.437/p < .001⁎ |
| Years of evolution (yrs.) | – | 4.16 (2.03) | – |
| H&Y (1:2:3:4:5) | – | 0:1:8:5:5 | – |
| PSPRS | – | 37.42 (10.08) | – |
| FAB⁎⁎ | – | 10.29 (2.67) | – |
HC: healthy controls; PSP: Progressive supranuclear palsy patient group; MMSE: Mini-mental state examination; H&Y: Hoehn and Yahr scale; PSPRS: Progressive Supranuclear Palsy Rating Scale; FAB: Frontal Assessment Battery
⁎
refers to significant results; Stats refers to Student's t-test (T) or Pearson's chi-square (χ2).
⁎⁎
PSP patients with FAB scale n = 14.